Hematology Tests Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$4000
Buy Report Download FREE Resources

Published: August 26, 2024 Report Code: GDME1803EPD-ST

Select Item

Hematology Tests Pipeline Market Report Overview

Hematology tests include various blood tests that diagnose and monitor various conditions. The hematology tests pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Territories ·       The United States

·       Europe

·       Chile

·       India

·       South Korea
Key Segment ·       Hemoglobin Point of Care (POC) Tests

·       White Blood Count Point of Care (POC) Tests

·       Other Hematology Rapid Tests & POC

·       Platelets Point of Care (POC) Tests

·       Rapid Haematology Tests (Point-Of-Care/Near Patient)
Key Regulatory Paths ·       510(k)

·       CE-IVD

·       MDITAC

·       ICAC

·       INVIMA
Leading Companies ·       Abionic SA

·       Aptitude Medical Systems Inc

·       Bio Vitos Pharma AB

·       Biochip Labs Inc

·       BioMedomics Inc
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Hematology Tests Pipeline Market Segments

A few of the key segments in the hematology tests pipeline market are Hemoglobin Point of Care (POC) Tests, White Blood Count Point of Care (POC) Tests, Other Hematology Rapid Tests & POC, Platelets Point of Care (POC) Tests, and Rapid Haematology Tests (Point-Of-Care/Near Patient) among others. As of August 2024, Hemoglobin Point of Care (POC) Tests have a higher number of pipeline products.

Hematology Tests Pipeline Market Analysis by Segments, 2024 (%)

Hematology Tests Pipeline Market Analysis by Segments, 2024 (%)

Buy the Full Report for More Segments Insights into the Hematology Tests Pipeline Market

Download a Free Report Sample

Hematology Tests Pipeline Market Segmentation by Territories

A few of the key territories with the hematology tests pipeline market are Europe, the United States, India, Chile, and South Korea among others. As of August 2024, the US had the highest number of hematology tests pipeline products.

Hematology Tests Pipeline Market Analysis by Territories, 2024 (%)

Hematology Tests Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Hematology Tests Pipeline Market

Download a Free Report Sample

Hematology Tests Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the hematology tests pipeline products market are 510(k), CE-IVD, MDITAC, ICAC, and INVIMA among others. As of August 2024, 510(k) was the most followed pathway for pipeline products in the hematology tests market.

Hematology Tests Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Hematology Tests Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Hematology Tests Pipeline Market

Download a Free Report Sample

Hematology Tests Pipeline Market – Competitive Landscape

A few of the key companies associated with the hematology tests pipeline market are Abionic SA, Aptitude Medical Systems Inc., Bio Vitos Pharma AB, Biochip Labs Inc., and BioMedomics Inc. among others.

Abionic SA: Abionic is a medical device company that develops, produces, and markets in vitro diagnostic devices. The company provides products such as abioGUIDE, abioGUIDE application for Android, iPhone, and iPad, and accessories, among others. Its abioSCOPE in vitro tests are designed to deliver specific, semi-quantitative, and personalized information about patients’ allergen sensitization at the point of care. Abionic offers abioGUIDE which application allows the user to see the results from the abioSCOPE directly on a mobile platform. The company’s IVD capsule test offers accurate information about patients’ respiratory allergies from a drop of blood. Its AbioGUIDE offers access to a complete database, showing cross-reactions with other allergens, as well as illustrations. Abionic is headquartered in Lausanne, Waadt, Switzerland.

Hematology Tests Pipeline Market Analysis by Companies, 2024
Hematology Tests Pipeline Market Analysis by Companies, 2024 Buy the Full Report for More Company Insights into the Hematology Tests Pipeline Market
Download a Free Report Sample

Segments Covered in the Report

Hematology Tests Pipeline Market Segments Outlook (2024)

  • Hemoglobin Point of Care (POC) Tests
  • White Blood Count Point of Care (POC) Tests
  • Other Hematology Rapid Tests & POC
  • Platelets Point of Care (POC) Tests
  • Rapid Haematology Tests (Point-Of-Care/Near Patient)

Hematology Tests Pipeline Market Territories Outlook (2024)

  • Europe
  • The United States
  • India
  • Chile
  • South Korea

Hematology Tests Pipeline Market Regulatory Paths Outlook (2024)

  • 510(k)
  • CE-IVD
  • MDITAC
  • ICAC
  • INVIMA

Scope

This report provides:

  • Extensive coverage of the Hematology Tests devices under development.

  • Exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.

  • Reviews of major players involved in the development of Hematology Tests and lists all their pipeline projects.

  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.

  • Key clinical trial data of ongoing clinical trials specific to pipeline products.

  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.

  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.

  • Identify and understand important and diverse types of hematology tests under development.

  • Develop market-entry and market-expansion strategies.

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.

  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Abionic SA
Aptitude Medical Systems Inc
Bio Vitos Pharma AB
Biochip Labs Inc
BioMedomics Inc
Biosurfit, SA
DxDiscovery Inc
Epimune GmbH
Flobio LLC
genedrive plc
Group K Diagnostics
Hemex Health Inc
McMaster University
MiCo BioMed Co Ltd
Ohio State University
Optolane Technologies Inc
PortaScience Inc
QSTAG Co Ltd
Retham Technologies LLC
rHealth
Sanguina LLC
ShanMukha Innovations Pvt Ltd
Siemens Healthcare Diagnostics Inc
Silver Lake Research Corporation
T2 Biosystems Inc
University of Melbourne
VitaMe Technologies Inc

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 8

2 Introduction 9

2.1 Hematology Tests Overview 9

3 Products under Development 10

3.1 Hematology Tests – Pipeline Products by Stage of Development 10

3.2 Hematology Tests – Pipeline Products by Segment 11

3.3 Hematology Tests – Pipeline Products by Territory 12

3.4 Hematology Tests – Pipeline Products by Regulatory Path 13

3.5 Hematology Tests – Pipeline Products by Estimated Approval Date 14

4 Hematology Tests – Pipeline Products under Development by Companies 15

4.1 Hematology Tests Companies – Pipeline Products by Stage of Development 15

4.2 Hematology Tests – Pipeline Products by Stage of Development 17

5 Hematology Tests Companies and Product Overview 19

5.1 Abionic SA Company Overview 19

5.1.1 Abionic SA Pipeline Products & Ongoing Clinical Trials Overview 19

5.2 Aptitude Medical Systems Inc Company Overview 25

5.2.1 Aptitude Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 25

5.3 Bio Vitos Pharma AB Company Overview 26

5.3.1 Bio Vitos Pharma AB Pipeline Products & Ongoing Clinical Trials Overview 26

5.4 Biochip Labs Inc Company Overview 27

5.4.1 Biochip Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 27

5.5 BioMedomics Inc Company Overview 28

5.5.1 BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview 28

5.6 Biosurfit, SA Company Overview 31

5.6.1 Biosurfit, SA Pipeline Products & Ongoing Clinical Trials Overview 31

5.7 DxDiscovery Inc Company Overview 33

5.7.1 DxDiscovery Inc Pipeline Products & Ongoing Clinical Trials Overview 33

5.8 Epimune GmbH Company Overview 34

5.8.1 Epimune GmbH Pipeline Products & Ongoing Clinical Trials Overview 34

5.9 Flobio LLC Company Overview 35

5.9.1 Flobio LLC Pipeline Products & Ongoing Clinical Trials Overview 35

5.10 genedrive plc Company Overview 36

5.10.1 genedrive plc Pipeline Products & Ongoing Clinical Trials Overview 36

5.11 Group K Diagnostics Company Overview 37

5.11.1 Group K Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 37

5.12 Hemex Health Inc Company Overview 38

5.12.1 Hemex Health Inc Pipeline Products & Ongoing Clinical Trials Overview 38

5.13 McMaster University Company Overview 40

5.13.1 McMaster University Pipeline Products & Ongoing Clinical Trials Overview 40

5.14 MiCo BioMed Co Ltd Company Overview 41

5.14.1 MiCo BioMed Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 41

5.15 Ohio State University Company Overview 42

5.15.1 Ohio State University Pipeline Products & Ongoing Clinical Trials Overview 42

5.16 Optolane Technologies Inc Company Overview 43

5.16.1 Optolane Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 43

5.17 PortaScience Inc Company Overview 44

5.17.1 PortaScience Inc Pipeline Products & Ongoing Clinical Trials Overview 44

5.18 QSTAG Co Ltd Company Overview 45

5.18.1 QSTAG Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 45

5.19 Retham Technologies LLC Company Overview 46

5.19.1 Retham Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 46

5.20 rHealth Company Overview 47

5.20.1 rHealth Pipeline Products & Ongoing Clinical Trials Overview 47

5.21 Sanguina LLC Company Overview 48

5.21.1 Sanguina LLC Pipeline Products & Ongoing Clinical Trials Overview 48

5.22 ShanMukha Innovations Pvt Ltd Company Overview 49

5.22.1 ShanMukha Innovations Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 49

5.23 Siemens Healthcare Diagnostics Inc Company Overview 50

5.23.1 Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 50

5.24 Silver Lake Research Corporation Company Overview 55

5.24.1 Silver Lake Research Corporation Pipeline Products & Ongoing Clinical Trials Overview 55

5.25 T2 Biosystems Inc Company Overview 56

5.25.1 T2 Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 56

5.26 University of Melbourne Company Overview 58

5.26.1 University of Melbourne Pipeline Products & Ongoing Clinical Trials Overview 58

5.27 VitaMe Technologies Inc Company Overview 59

5.27.1 VitaMe Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 59

6 Hematology Tests- Recent Developments 60

6.1 Jul 22, 2024: Relentless Health to Partner with Firefighters to Deliver PFAS Testing 60

6.2 Jun 19, 2024: Quest Diagnostics to Release Second Quarter 2024 Financial Results on July 23, 2024 60

6.3 May 08, 2024: Biohit Notice of Annual General Meeting 60

6.4 May 07, 2024: Siemens Healthineers on Track to Meet Fiscal Year 2024 Targets After Second Quarter 64

6.5 May 07, 2024: Quest Diagnostics to Speak at the 2024 Leerink Partners Healthcare Crossroads Conference 66

6.6 Apr 03, 2024: PatientPoint Appoints Sean Slovenski as President to Drive Innovation and Growth 66

6.7 Mar 19, 2024: Quest Diagnostics to Release First Quarter 2024 Financial Results on April 23, 2024 67

6.8 Mar 18, 2024: Siemens Healthineers Intends to Close Fast Track Diagnostics 67

6.9 Feb 05, 2024: Study of First Affordable and Rapid Test for Beta Thalassemia Performs at 99% Accuracy in Diagnosing the Blood Disorder 67

6.10 Jan 17, 2024: Capitainer Opens New qDBS Microsampling Laboratory in Rhode Island, U.S. 68

6.11 Jan 02, 2024: Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan’s 42nd Annual Healthcare Conference 68

6.12 Nov 13, 2023: ARUP receives CE mark for AAV5 DetectCDx test 68

6.13 Oct 25, 2023: Sanguina Receives CLIA Approval For AnemoCheck Home 69

6.14 Oct 19, 2023: Sanguina Obtains Additional 510(k) Clearance for AnemoCheck 69

6.15 Oct 18, 2023: FloBio gets FDA breakthrough device status for bleeding risk diagnostic test 69

6.16 Oct 05, 2023: Sanguina receives US FDA clearance for haemoglobin test kit 70

6.17 Sep 29, 2023: ARUP’s New Institute for Research and Innovation in Diagnostic and Precision Medicine Will Forge the Future of Laboratory Medicine 71

6.18 Sep 11, 2023: Capitainer-backed initiative in personalized medicine and diagnostics secures a SEK 12 million boost from KK-stiftelsen 72

6.19 Sep 08, 2023: Quest Diagnostics to Speak at the Baird 2023 Global Healthcare Conference 72

6.20 Aug 28, 2023: Bio-Rad to Participate in Fireside Chat During Wells Fargo’s 2023 Healthcare Conference 73

7 Appendix 74

7.1 Methodology 74

7.2 About GlobalData 77

7.3 Contact Us 77

7.4 Disclaimer 77

Table

Hematology Tests – Pipeline Products by Stage of Development 10

Hematology Tests – Pipeline Products by Segment 11

Hematology Tests – Pipeline Products by Territory 12

Hematology Tests – Pipeline Products by Regulatory Path 13

Hematology Tests – Pipeline Products by Estimated Approval Date 14

Hematology Tests Companies – Pipeline Products by Stage of Development 15

Hematology Tests – Pipeline Products by Stage of Development 17

Abionic SA Pipeline Products & Ongoing Clinical Trials Overview 19

Point of Care Diagnostic Test – Basophils – Product Status 19

Point of Care Diagnostic Test – Basophils – Product Description 20

Point of Care Diagnostic Test – Eosinophils – Product Status 20

Point of Care Diagnostic Test – Eosinophils – Product Description 20

Point of Care Diagnostic Test – Erythrocyte – Product Status 21

Point of Care Diagnostic Test – Erythrocyte – Product Description 21

Point of Care Diagnostic Test – Hemoglobin – Product Status 21

Point of Care Diagnostic Test – Hemoglobin – Product Description 22

Point of Care Diagnostic Test – Lymphocytes – Product Status 22

Point of Care Diagnostic Test – Lymphocytes – Product Description 22

Point of Care Diagnostic Test – Neutrophils – Product Status 23

Point of Care Diagnostic Test – Neutrophils – Product Description 23

Point of Care Diagnostic Test – Thrombocytes – Product Status 23

Point of Care Diagnostic Test – Thrombocytes – Product Description 24

Point of Care Diagnostic Test – White Blood Cells – Product Status 24

Point of Care Diagnostic Test – White Blood Cells – Product Description 24

Aptitude Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 25

POC Test – Trauma Coagulopathy – Product Status 25

POC Test – Trauma Coagulopathy – Product Description 25

Bio Vitos Pharma AB Pipeline Products & Ongoing Clinical Trials Overview 26

v-Test – Serum Tubes – Product Status 26

v-Test – Serum Tubes – Product Description 26

Biochip Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 27

Endothelium-on-a-Chip Assay – Product Status 27

Endothelium-on-a-Chip Assay – Product Description 27

BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview 28

Fetomaternal Hemorrhage Test – Product Status 28

Fetomaternal Hemorrhage Test – Product Description 28

Hemo SCAN – Product Status 29

Hemo SCAN – Product Description 29

Hemo SCAN S – Product Status 29

Hemo SCAN S – Product Description 30

Rapid Quantitative Heparin-Induced Thrombocytopenia (H.I.T.) Test – Product Status 30

Rapid Quantitative Heparin-Induced Thrombocytopenia (H.I.T.) Test – Product Description 30

Biosurfit, SA Pipeline Products & Ongoing Clinical Trials Overview 31

Spinit Device – Blood Quantitation Anemia Assay – Product Status 31

Spinit Device – Blood Quantitation Anemia Assay – Product Description 31

Spinit Device – Thrombocytopenia Assay – Product Status 32

Spinit Device – Thrombocytopenia Assay – Product Description 32

DxDiscovery Inc Pipeline Products & Ongoing Clinical Trials Overview 33

Diagnostic Assay – Sickle Cell Disease – Product Status 33

Diagnostic Assay – Sickle Cell Disease – Product Description 33

Epimune GmbH Pipeline Products & Ongoing Clinical Trials Overview 34

i.Mune Tbnk Test – Product Status 34

i.Mune Tbnk Test – Product Description 34

Flobio LLC Pipeline Products & Ongoing Clinical Trials Overview 35

DOAC Diagnostic Assay – Product Status 35

DOAC Diagnostic Assay – Product Description 35

genedrive plc Pipeline Products & Ongoing Clinical Trials Overview 36

Genedrive – Factor V Leiden – Product Status 36

Genedrive – Factor V Leiden – Product Description 36

Group K Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 37

KromaHealth Kit – Complete Blood Count – Product Status 37

KromaHealth Kit – Complete Blood Count – Product Description 37

Hemex Health Inc Pipeline Products & Ongoing Clinical Trials Overview 38

Gazelle Hb Variant Test – Product Status 38

Gazelle Hb Variant Test – Product Description 38

RHODA – Product Status 39

RHODA – Product Description 39

McMaster University Pipeline Products & Ongoing Clinical Trials Overview 40

aFXa DOAC Assay – Product Status 40

aFXa DOAC Assay – Product Description 40

MiCo BioMed Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 41

Labchip Based Test – Hemoglobin – Product Status 41

Labchip Based Test – Hemoglobin – Product Description 41

Ohio State University Pipeline Products & Ongoing Clinical Trials Overview 42

Diagnostic Assay – Thrombotic Thrombocytopenic Purpura – Product Status 42

Diagnostic Assay – Thrombotic Thrombocytopenic Purpura – Product Description 42

Optolane Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 43

Molecular Dx – Thrombosis Panel – Product Status 43

Molecular Dx – Thrombosis Panel – Product Description 43

PortaScience Inc Pipeline Products & Ongoing Clinical Trials Overview 44

PortaWBC – Product Status 44

PortaWBC – Product Description 44

QSTAG Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 45

Qscheck – BISNUTRA Kit – Product Status 45

Qscheck – BISNUTRA Kit – Product Description 45

Retham Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 46

HITDx – Product Status 46

HITDx – Product Description 46

rHealth Pipeline Products & Ongoing Clinical Trials Overview 47

Diagnostic Test – Thrombocytopenia – Product Status 47

Diagnostic Test – Thrombocytopenia – Product Description 47

Sanguina LLC Pipeline Products & Ongoing Clinical Trials Overview 48

AnemoCheck Home – Product Status 48

AnemoCheck Home – Product Description 48

ShanMukha Innovations Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 49

SickleFind – Product Status 49

SickleFind – Product Description 49

Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 50

ADVIA 120 Hematology System – IRF Test – Product Status 50

ADVIA 120 Hematology System – IRF Test – Product Description 50

ADVIA 120 Hematology System – MPC Test – Product Status 51

ADVIA 120 Hematology System – MPC Test – Product Description 51

ADVIA 120 Hematology System – MPM Test – Product Status 51

ADVIA 120 Hematology System – MPM Test – Product Description 51

ADVIA 2120 Hematology System – MPC Test – Product Status 52

ADVIA 2120 Hematology System – MPC Test – Product Description 52

ADVIA 2120 Hematology System – MPM Test – Product Status 52

ADVIA 2120 Hematology System – MPM Test – Product Description 53

ADVIA 2120i Hematology System – MPC Test – Product Status 53

ADVIA 2120i Hematology System – MPC Test – Product Description 53

ADVIA 2120i Hematology System – MPM Test – Product Status 54

ADVIA 2120i Hematology System – MPM Test – Product Description 54

Silver Lake Research Corporation Pipeline Products & Ongoing Clinical Trials Overview 55

HemoTypeBT – Product Status 55

HemoTypeBT – Product Description 55

T2 Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 56

T2HemoStat – Product Status 56

T2HemoStat – Product Description 56

T2MR Assay – Platelet Function Testing – Product Status 57

T2MR Assay – Platelet Function Testing – Product Description 57

University of Melbourne Pipeline Products & Ongoing Clinical Trials Overview 58

Thrombin Generation Assay – Product Status 58

Thrombin Generation Assay – Product Description 58

VitaMe Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 59

Iron.Scan – Product Status 59

Iron.Scan – Product Description 59

Glossary 76

Figures

Hematology Tests – Pipeline Products by Stage of Development 10

Hematology Tests – Pipeline Products by Segment 11

Hematology Tests – Pipeline Products by Territory 12

Hematology Tests – Pipeline Products by Regulatory Path 13

Hematology Tests – Pipeline Products by Estimated Approval Date 14

Frequently asked questions

Hematology Tests Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

Most Popular
$8,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Hematology Tests Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Hematology Tests reports
Medical Devices
New
Global M&A Deals in H1 2026 - Top Themes by…
$495 | August 2026
Medical Devices
New
Medical Devices M&A Deals H1 2026 - Top Themes: Strategic…
$495 | July 2026
Medical Devices
New
AI-designed Materials: Market Trends and Innovations
$995 | July 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Hematology Tests Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Hematology Tests Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more